|
Re: AGM attendance
|
4
|
Resverlogix Corp.
|
May 24, 2022 08:37PM
|
|
Re: Another variation
|
9
|
Resverlogix Corp.
|
Mar 04, 2021 07:48AM
|
|
Re: Another variation
|
8
|
Resverlogix Corp.
|
Mar 04, 2021 09:40AM
|
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
8
|
Resverlogix Corp.
|
Mar 03, 2021 11:44AM
|
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
11
|
Resverlogix Corp.
|
Mar 18, 2021 10:33AM
|
|
Re: approx. 85,000 deferred share units awarded
|
11
|
Resverlogix Corp.
|
Nov 05, 2020 03:44PM
|
|
Re: BTD
|
13
|
Resverlogix Corp.
|
Apr 24, 2022 09:25AM
|
|
Re: can it be done legally
|
1
|
Resverlogix Corp.
|
Dec 14, 2022 10:11PM
|
|
Re: China- 1 Million daily COVID cases
|
4
|
Resverlogix Corp.
|
Jan 01, 2023 09:21AM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
4
|
Resverlogix Corp.
|
Apr 14, 2021 10:51PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
2
|
Resverlogix Corp.
|
Apr 14, 2021 11:22PM
|
|
Re: Covid
|
4
|
Resverlogix Corp.
|
Aug 12, 2022 05:55PM
|
|
Re: Dead money.
|
8
|
Resverlogix Corp.
|
Nov 20, 2020 04:01PM
|
|
Re: Debt and 28 August
|
6
|
Resverlogix Corp.
|
Jul 28, 2017 09:40AM
|
|
Re: Debt and 28 August
|
1
|
Resverlogix Corp.
|
Jul 28, 2017 11:20AM
|
|
Re: Debt and 28 August
|
3
|
Resverlogix Corp.
|
Aug 03, 2017 11:02AM
|
|
Re: Do we have the votes?
|
3
|
Resverlogix Corp.
|
Jul 13, 2024 01:32PM
|
|
Re: Don's latest presentation
|
8
|
Resverlogix Corp.
|
Sep 22, 2020 08:02PM
|
|
Re: Dr. Wong retires - Dr. Kulikowski in as CSO
|
9
|
Resverlogix Corp.
|
Aug 17, 2022 12:27AM
|
|
Re: Epizyme market cap $750 mil USd
|
3
|
Zenith Epigenetics
|
Jun 18, 2017 08:47AM
|
